Decision
The aggressive analyst presents the most compelling case, supported by concrete data and historical lessons:
Technical Asymmetry Favors Upside: Current price ($324.74) is near critical support ($312-313) with oversold extremes (RSI 24.06, J-value -12.80). Historical data shows mean reversion effectiveness: Previous holds (Feb 9 and Feb 6) achieved +18.75% and +6.56% returns when buying near support. Past mistakes (Feb 19-20 buys) occurred at overbought levels ($369-$375), not oversold ones. Current setup mirrors successful entries, not failures.
Fundamental Catalysts Are Timely: AI demand cycle is “early stage” (Aggressive Analyst), with Morgan Stanley’s upgraded target ($432) reflecting concrete DRAM/HBM spending forecasts, not speculation. Regulatory overhang reduced via U.S. government settlement, and global diversification offsets China risks.
Risk Management Alignment with History: Stop-loss at $310 (below 60-day MA and February low) limits downside to 4.5%, below the historical maximum adverse excursion (-9.74% from worst cases). Holder concentration risk is mitigated by oversold conditions: Institutional selling near support is less probable (evidenced by Feb rebounds). Valuation concerns (P/E 35.08x) are countered by AI growth trajectory and margins justifying premium.